glp 1 oral tablets Foundayo vs Rybelsus: The GLP-1 Guide for 2026 GLP-1 Weight-Loss Pills: What You

Southend, for instance, is reportedly tweaking its concentration to avoid being considered a copy

JAMA 330 , 512527 (2023)

Even accounting for long-term health gains, the researchers found that GLP-1 drugs fall well short of standard benchmarks for cost-effectiveness

That status changed in December 2025 with the FDA approval of an oral version of Wegovy (also manufactured by Novo Nordisk)

This is because obesity is a major risk factor for numerous health conditions, including heart disease, stroke, high blood pressure and at least 13 different types of cancer, according to the Centers for Disease Control and Prevention

So he is eligible for a new treatment for now, liraglutide, via tier 3 weight management services